Langue d'origine | English |
---|---|
Pages (de-à) | 383-393 |
Nombre de pages | 11 |
Journal | Journal of the Canadian Urological Association |
Volume | 15 |
Numéro de publication | 12 |
DOI | |
Statut de publication | Published - déc. 2021 |
Note bibliographique
Funding Information:Competing interests: Dr. Lee has received a speaker honorarium from Baxter. Dr. Bhojani has reviewed new products for Boston Scientific and participated in WATER 2, an Aquablation multi-institutional clinical trial supported by Procept. Dr. Chew has been a consultant for Auris Robotics, Bard Medical, Boston Scientific, and Olympus; has been a lecturer for Boston Scientific, Coloplast, Cook Medical, and Olympus; received a study grant from Boston Scientific; received a fellowship salary from Cook Medical; and participated in clinical trials supported by Boston Scientific and Cook Medical. Dr. Elmansy has received payment from Boston Scientific, Clarion Medical Technologies/ AccuTech Medical Technologies, and Janssen; and received speaker honoraria and a travel grant from Lumenis. Dr. Pace has received support for a fellowship and annual lectureship from Cook Urological. The remaining authors report no competing personal or financial interests related to this work.
ASJC Scopus Subject Areas
- Oncology
- Urology
PubMed: MeSH publication types
- Journal Article